Cytosorbents (CTSO) Tops Q2 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $9.9 million versus the consensus estimate of $9.68 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
• UBS Upgrades FuelCell Energy (FCEL) to Buy, 'we would be buyers ahead of any capacity expansion announcement'
• Nebius to sell over $1B in computing power to Reflection AI